Sumitomo Mitsui Ds Asset Management Company, LTD Alnylam Pharmaceuticals, Inc. Transaction History
Sumitomo Mitsui Ds Asset Management Company, LTD
- $12.1 Billion
- Q3 2025
A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 15,826 shares of ALNY stock, worth $7.11 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
15,826
Previous 14,808
6.87%
Holding current value
$7.11 Million
Previous $4.83 Million
49.46%
% of portfolio
0.06%
Previous 0.04%
Shares
25 transactions
Others Institutions Holding ALNY
# of Institutions
917Shares Held
115MCall Options Held
1.26MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA16.4MShares$7.38 Billion1.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$6.09 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.29 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.22MShares$3.24 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY4.54MShares$2.04 Billion0.14% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $55.3B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...